Perspective Therapeutics (CATX)

• Market cap: $598M
• 1 day: 3.75%
• 5 days: -5.06%
• 1 month: 94.44%
• 3 months: 123.4%
• 6 months: 45.43%
• Year to date: 88.17%
• 1 year: 101.15%
• 5 years: -65.46%
• 10 years: -35.98%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Employees: 140